Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new podcast Sallie Lamb, Head of the Rehabilitation Research Group at NDORMS talks about SARAH, the Strengthening and Stretching for Rheumatoid Arthritis of the Hand Trial.

SARAH logo

The trial has been identified as one of the five most important randomised controlled trials in physiotherapy published in the last 5 years by PEDro (which stands for Physiotherapy Evidence Database).The trials were nominated by PEDro users and an independent panel of international trialists to celebrate PEDro's 20th birthday. Listen to Sallie's podcast here

Entitled 'Exercises to Improve function of the Rheumatoid Hand' (SARAH), the trial appeared in the Lancet in January 2015.

PEDro is a free database of over 45,000 randomised trials, systematic reviews and clinical practice guidelines in physiotherapy. It is produced by the Institute for Musculoskeletal Health, School of Public Health at the University of Sydney and is hosted by Neuroscience Research Australia and can be found at: https://www.pedro.org.au/

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.